Weight Loss & Metabolic Health

(Retatrutide, Tirzepatide, Semaglutide)

You don’t have a willpower problem. You have a metabolic signaling problem.
Our program blends precision pharmacology (GLP-1/GIP/Glucagon agonists like semaglutide, tirzepatide, or retatrutide) with nutrition, movement, and hormonal optimization to fix what caused the weight gain—not just suppress appetite.

Why This Program Works

  • We treat the root, not the scale number.

  • We restore leptin, insulin, and GLP-1 physiology, not chase calories.

  • We optimize body composition, not starvation and rebound weight gain.

  • And yes—it’s all virtual for Texas residents.

Who It’s For

  • Persistent weight gain or plateau despite diet/exercise.

  • Insulin resistance or prediabetes (A1c 5.6–6.4%, BMI > 28, Hyperlipidemia).

  • Metabolic syndrome: elevated triglycerides, low HDL, central adiposity, elevated fasting insulin.

  • Post-TRT weight stalls due to uncorrected insulin resistance.

  • Patients transitioning off extreme diets (keto, carnivore, etc.) who need metabolic reset.

Evaluation Protocol

Baseline Labs

  • CMP, CBC, fasting glucose, fasting insulin (calculate HOMA-IR)

  • A1c, lipid panel (apoB optional)

  • TSH/FT4/FT3, morning cortisol (optional), leptin (if obese)

  • Testosterone, estradiol, SHBG

  • ALT/AST (to monitor hepatic metabolism), B12, folate, Amylase, Lipase

Optional advanced labs

  • Fasting C-peptide

  • Adiponectin, hs-CRP

Treatment Framework

1. Pharmacologic Foundation

GLP-1 / GIP analogs rebalance appetite regulation and energy efficiency:

  • Semaglutide (Ozempic®, Wegovy®, compounded) — weekly, titrated.

  • Tirzepatide (Mounjaro®, Zepbound®, compounded) — dual incretin agonist, faster metabolic correction.

  • Retatrutide (triple agonist) — GLP-1/GIP/glucagon triple agonist peptide—essentially the most potent of the incretin-mimetic class so far. It works by:

    • Suppressing appetite and slowing gastric emptying (GLP-1 effect)

    • Enhancing insulin secretion and improving insulin sensitivity (GIP effect)

    • Boosting resting energy expenditure and fat oxidation (glucagon receptor effect)

    • Clinical studies show greater and faster weight loss than semaglutide or tirzepatide, with many patients hitting >20% body-weight reduction at higher doses.

We use individualized titration schedules to minimize nausea, fatigue, and muscle loss.
Adjuncts like BPC-157, L-carnitine, or NAD⁺ may support recovery and performance.

2. Nutritional Precision

We teach macronutrient timing and metabolic leverage:

  • Emphasis on protein-first, moderate carb/carb cycling, and anti-inflammatory fat ratios.

  • Support gut-brain satiety signaling through fiber and polyphenols.

  • Use continuous glucose monitoring (CGM) when needed for real-time data.

3. Strength & NEAT Restoration

Muscle drives metabolism.
We prefer low/moderate-volume resistance training + daily NEAT (non-exercise activity thermogenesis) goals to preserve lean mass and raise resting metabolic rate.

4. Hormonal & Sleep Integration

Correct testosterone, thyroid, cortisol, and melatonin rhythms to prevent GLP-1 resistance and post-drug rebound.
Sleep hygiene, circadian timing, and HRV tracking are built into follow-ups.

What Working With Us Looks Like

  1. Initial consult → discuss pharmacologic + lifestyle plan.

  2. Initiation phase (first 4–6 weeks) → titrate dose, track side effects.

  3. Optimization phase (weeks 8–24) → metabolic adaptation, body composition monitoring.

  4. Maintenance phase → transition off GLP-1s safely with metabolic resiliency protocols.

Safety & Monitoring

  • Regular labs every 3-6 months during titration.

  • Monitor for GI side effects, hypoglycemia (rare), dehydration, and gallbladder symptoms.

  • Reinforce hydration, electrolytes, protein intake, and resistance training.

Pricing

Transparent program fees and medication costs listed on the Pricing page.

FAQs

Do you use compounded GLP-1s?
Yes—only from FDA-registered 503A/503B compounding pharmacies we vet for sterility, potency, and source transparency.

Do you treat patients not yet obese?
Yes. We focus on insulin resistance prevention, not just treatment of advanced metabolic disease.

Do I need to stay on it forever?
No. We build a reverse-taper strategy that maintains metabolic health off medication.

What if I hit a plateau?
We analyze HRV, resting energy, and muscle trends, not just scale weight. Adjust dose, add movement, or modify macro ratios before escalating medication.

Final CTA

You don’t need another fad diet—you need a reset button for metabolic signaling.
We’ll help you build it, measure it, and maintain it.

Related Care: